Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...

Key Points Revenue (GAAP) reached $124.1 million, surpassing the $115.5 million GAAP estimate and rising 29.7% year-over-year. Non-GAAP earnings per share improved to ($0.24), beating expectations and ...